Blood Test from Alliance Trial Reveals Anti-Inflammatory Drug’s Potential to Reduce Colon Cancer Recurrence Risks
The Alliance for Clinical Trials in Oncology has recently unveiled compelling findings from a randomized phase III clinical trial focused ...